Enhanced monocyte migration into the lungs of patients with IPF occurs in response to increased production of CCL2 (or monocyte chemoattractant protein-1, MCP1) by endothelial cells and increased serum CCL2 concentrations [157,158]. Here, CCL2 is linked to idiopathic pulmonary fibrosis.